Drug Listing U.S. Agent vs Food Facility U.S. Agent: Two FDA Programs, One Label
Updated: Oct 6
A foreign manufacturer that ships both a food product and a drug product to the United States needs a U.S. Agent for each. Not one Agent covering both — one appointment in the food facility registration program and a separate appointment in the drug establishment registration program. The two roles share a name and a physical-presence rule, and almost nothing else: different regulations, different portals, different filing cadences, and different duties. Mixing them up is one of the most common reasons a first shipment sits at the port while a registration is corrected.
This is the side-by-side we use with clients who make both. For the food-only first path, read our foreign food facility registration guide. For the drug-only listing mechanics, read our drug listing, SPL and NDC explainer.
What is a food facility U.S. Agent?
Under 21 CFR 1.227, a U.S. agent is a person residing or maintaining a place of business in the United States whom a foreign facility designates as its agent for the purposes of food facility registration. The agent may not be a mailbox, answering machine or service, or other place where an individual acting as the foreign facility's agent is not physically present.
The regulation gives the food Agent two defined jobs. First, the U.S. agent acts as a communications link between FDA and the foreign facility for both emergency and routine communications, and is the person FDA contacts when an emergency occurs unless the registration names another emergency contact. Second, FDA will treat representations by the U.S. agent as those of the foreign facility, and will consider information or documents provided to the U.S. agent the equivalent of providing them to the facility.
The appointment is also a gate on the registration itself. Under 21 CFR 1.231(a)(5), after a foreign facility submits its electronic registration, FDA verifies that the person identified as the U.S. agent has agreed to serve, and FDA will not confirm the registration or provide a registration number until that person confirms. The same check runs again when Agent information is updated at renewal.
Registration is filed in the Food Facility Registration Module of FDA Industry Systems, and under 21 CFR 1.230(b) it is renewed every other year between October 1 and December 31 of each even-numbered year. Our food facility registration and renewal service covers this lane.
What is a drug establishment U.S. Agent?
Under 21 CFR 207.69(b), registrants of foreign drug establishments must designate a single United States agent, who must reside or maintain a place of business in the United States and may not be a mailbox, answering machine or service, or other place where a person acting as the United States agent is not physically present. The physical-presence language is close to the food rule. The duties are not.
Part 207 makes the drug Agent responsible for four things: reviewing, disseminating, routing, and responding to all communications from FDA including emergency communications; responding to questions concerning those drugs that are imported or offered for import to the United States; assisting FDA in scheduling inspections; and, if FDA is unable to contact a foreign registrant directly or expeditiously, receiving information and documents on the registrant's behalf, which FDA treats as equivalent to providing them to the foreign registrant.
Two of those — answering import questions and helping schedule inspections — have no counterpart in the food definition.
Part 207 also requires a second person the food program does not: an official contact for each establishment, responsible under 21 CFR 207.69(a) for ensuring the accuracy of registration and listing information and for handling all FDA communications. The official contact and the U.S. Agent can be the same person, but they are separate fields, and both have to be kept current.
The drug program is also two filings, not one. Under 21 CFR 207.17, each foreign establishment that manufactures, repacks, relabels, or salvages a drug that is imported or offered for import must register, and under 21 CFR 207.21(b) that registration must be in place before the drug is imported or offered for import. Then, under 21 CFR 207.41, each registrant must list each drug it manufactures, repacks, relabels, or salvages for commercial distribution. Both are submitted in Structured Product Labeling (SPL) format, an XML standard, through FDA's electronic drug registration and listing system. FDA's eDRLS page states plainly that registering an establishment and listing drugs with FDA does not indicate the products are approved or that FDA has verified the information provided. The NDC and SPL mechanics are covered in our drug listing and SPL service page.
Side-by-side: food facility Agent vs drug establishment Agent
Food facility U.S. Agent | Drug establishment U.S. Agent | |
|---|---|---|
Regulation | 21 CFR Part 1, Subpart H (definition at 1.227) | 21 CFR Part 207 (Agent at 207.69(b)) |
Portal | Food Facility Registration Module, FDA Industry Systems | Electronic Drug Registration and Listing System (SPL/XML, via FDA Direct or the Electronic Submissions Gateway) |
What is filed | Facility registration (one filing per facility) | Establishment registration and drug listing (two filings; listing carries the NDC and label content) |
Physical presence rule | Yes — no mailbox, answering service or absent-person address | Yes — same exclusion, same words |
Defined duties | Communications link, emergency contact; FDA treats Agent's representations as the facility's | All FDA communications; questions on imported drugs; assisting FDA in scheduling inspections; receiving documents when FDA cannot reach the registrant |
Second required role | None | Official contact (207.69(a)) — may be the same person, separate field |
Agent confirmation gate | FDA will not confirm registration until the named Agent confirms (1.231(a)(5)) | Not a confirmation step in the same form; Agent is a registration data element kept current under 207.29 |
Initial timing | Register before the facility begins handling food for U.S. consumption (1.230(a)) | Register before the drug is imported or offered for import (207.21(b)) |
Renewal / update cadence | Renew every other year, Oct 1–Dec 31 of even-numbered years (1.230(b)); 2026 is a renewal year | Review and update registration annually Oct 1–Dec 31 (207.29(b)); review and update listing every June and December (207.57(b)); expedited update within 30 days for Agent or contact changes (207.29(a)) |
Axentra fee posture | $249 per facility per year for food, dietary supplements and cosmetics, with a 2-year price lock; API, OTC, pharma and device work is quoted by class | Drug establishment Agent and listing/SPL work quoted by class (API, OTC, finished pharma) — not the food/cosmetics/DS Agent lane |
Four mix-ups we see most
One Agent letter for both programs. A food Agent designation lives in the facility registration record; a drug Agent designation lives in the establishment's SPL registration file. Naming Axentra in one does nothing in the other. Each program needs its own appointment.
Assuming "annual" means the same thing. Food facility registration renews biennially in even-numbered years. Drug establishment registration is reviewed every year in the fourth quarter, and drug listing has its own June and December review. Renewing the food registration in December 2026 does not cover the drug side until 2028.
Dietary supplements are food. A dietary supplement facility registers under Part 1, Subpart H, with a food facility U.S. Agent — not under Part 207. Supplement labeling and claims have their own rules, but the registration and Agent lane is the food one. Our dietary supplement compliance page covers the layers on top.
OTC drugs are not cosmetics. A sunscreen or an anti-dandruff shampoo is an OTC drug in the United States and sits in the Part 207 registration and listing lane with a drug Agent, even when the same company's other products are cosmetics. Cosmetics use a different portal under MoCRA; see our MoCRA cosmetics page. For the OTC lane, see OTC drug and sunscreen registration.
None of these filings — food registration, drug registration, drug listing, or the Agent appointment in either — means FDA has approved the product or reviewed the facility. They are registrations, not clearances.
How Axentra serves both programs
We act as U.S. Agent in both lanes from our Albuquerque office, with a person physically present to take the call.
For food facilities, our U.S. Agent service is $249 per facility per year for food, dietary supplements and cosmetics, with a 2-year price lock; API, OTC, pharma and device work is quoted by class. We can file the registration or biennial renewal alongside it.
For drug establishments, we quote the Agent appointment and the listing/SPL work by product class — API, OTC monograph products, finished pharmaceuticals — because the filing scope, the NDC and labeler code setup, and the ongoing June/December listing maintenance differ from one to the next. Start at our drug listing and SPL page or tell us what you make and we will map which program, or programs, apply.
Axentra Global Pharma Compliance LLC · 1209 Mountain Road Pl NE, Suite N, Albuquerque, NM 87110 · 505-358-4858 · info@axentracompliance.com
Frequently asked questions
What is the difference between a food facility U.S. Agent and a drug establishment U.S. Agent?
They are separate appointments under separate regulations. The food facility U.S. Agent is defined in 21 CFR 1.227 and named in the facility's food registration; the drug establishment U.S. Agent is required by 21 CFR 207.69(b) and named in the establishment's SPL registration file. Both must be physically present in the United States, but the drug Agent's duties also include answering questions about imported drugs and assisting FDA in scheduling inspections, and the drug program also requires an official contact. A company that makes both food and drug products needs an Agent designation in each program.
Does drug listing mean FDA approval?
No. FDA states that registering an establishment and listing drugs with FDA does not indicate the products are approved or that FDA has verified the information provided. Listing assigns and records the NDC and label content for a marketed drug; it is not a review of safety or effectiveness. The same is true of food facility registration, which is a registration, not a clearance.
Where do Axentra's U.S. Agent fees apply?
Axentra's U.S. Agent service is $249 per facility per year for food, dietary supplements and cosmetics, with a 2-year price lock. Drug establishment Agent appointments and drug listing or SPL work are quoted by product class, because the filing scope and ongoing listing maintenance differ by product.
Related reading
Sources (opened 24 September 2026)
21 CFR 1.227 — definitions, U.S. agent (eCFR, up to date as of 9/22/2026)
21 CFR 1.230 — when to register or renew (eCFR, 9/22/2026)
21 CFR 1.231 — how and where to register; Agent confirmation, paragraph (a)(5) (eCFR, 9/22/2026)
21 CFR 207.17, 207.21, 207.29, 207.41, 207.57, 207.69 — drug establishment registration, listing, updates, official contact and U.S. agent (eCFR, 9/22/2026)
FDA, Electronic Drug Registration and Listing System (eDRLS) — "does not indicate the products are approved" (content current 02/05/2026)
FDA, Drug Registration and Listing Instructions — SPL/XML format, FDA Direct, ESG NextGen (content current 08/03/2026)
FDA, Online Registration of Food Facilities — FDA Industry Systems / Food Facility Registration Module (content current 02/11/2026)
Comments